PropertyValue
?:abstract
  • The prognosis of patients with the coronavirus disease 2019 (COVID-19) is determined by the severity of lower respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The majority of patients demonstrate mild symptoms only. However, development of pneumonia is associated with the risk of severe respiratory insufficiency. Reverse transcriptase polymerase chain reaction (RT-PCR) of specimens from the upper and/or lower respiratory tract is the gold standard for the diagnosis of COVID-19. Radiology and especially high-resolution computed tomography (HRCT) are important for diagnosis and follow-up. This narrative review provides an overview of clinical signs and the complex and unique pathophysiology of COVID-19 pneumonia. Radiological features are addressed. Therapy is mainly supportive with the most important task being management of respiratory insufficiency. Recently, promising data were presented regarding effectiveness of antiviral and anti-inflammatory drugs.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1007/s11377-020-00488-x
?:journal
  • Gastroenterologe
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/0009745a11d206af9e405e00677c51b01251dba7.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7656100.xml.json
?:pmcid
?:pmid
?:pmid
  • 33200006.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID-19-Pneumonie
?:type
?:year
  • 2020-11-11

Metadata

Anon_0  
expand all